Who is a Class Member
The Stony Hollow Landfill class action settlement includes “all persons in the United States who purchased a Lang CoQ-10 Softgel product manufactured by Lang Pharma Nutrition, Inc. (Lang CoQ-10 Softgel”) and sold under store brand labels by CVS, Walmart, Walgreens and Meijer, from July 1, 2013 until July 24, 2018.
Covered products include:
- Wal-Mart’s Equate Clinical Strength High Absorption CoQ-10 100 mg
- CVS/Pharmacy Ultra CoQ-10 100 mg
- CVS/Health Ultra CoQ-10 100 mg
- CVS/Pharmacy Enhanced Absorption Formula CoQ-10 100 mg
- CVS/Health Enhanced Absorption Formula CoQ-10 100 mg
- Walgreens Well at Walgreens CoQ-10 Enhanced Absorption Formula 100 mg
- Walgreens Well at Walgreens CoQ-10 Enhanced Absorption Formula 200 mg
- Meijer’s Ultra CoQ-10 100 mg (Meijer Ultra CoQ-10)
If you don’t qualify for this settlement, check out our database of other class action settlements you may be eligible for.
Settlement Amount
- $1,306,000.00
Estimated Award
- $3.50 Cash or $12.50 Product Credit
Claimants can opt to receive either a $3.50 cash payout or a $12.50 product credit redeemable for a variety of Lang Pharma dietary supplements.
Proof of Purchase
- N/A
Claim Form
Co-Q10 Supplements Settlement Notes
- William Jackson, et al. v. Lang Pharma Nutrition Inc., et al.
- Case No. 37-2017-00028196-CU-BC-CTL
- Pending in the Superior Court of California for the County of San Diego
In November 2017, plaintiffs William Jackson, Edward Buchannan, and Thamar Santisteban Cortina filed this class action lawsuit against Lang Pharma Nutrition and several retailers alleging the defendants violated certain California laws by misleadingly labeling their CoQ-10 supplement as being more effective than they are and has having greater absorption rates then they do.
Lang Pharma manufacturers a CoQ-10 supplement product which is sold by Walmart, CVS, Walgreens, and Meijer under their own store brand names.
Coenzyme Q-10 or Co-Q10 is a nutrient with proven health benefits, but also a well-known drawback: it is not soluble in water, and poorly soluble in fat. This is problematic for consumers who use CoQ-10 supplements because the body and digestive tract are aqueous, and the absorption of a substance depends on its first dissolving. To address this problem, some dietary supplement manufacturers have invented technologies for modifying orally-administered CoQ-10 to increase its solubility, and thereby its bioavailability.
All defendants deny the allegations and maintain that the CoQ-10 supplement are effective and achieve the stated absorption rates. Complete details about the case and settlement are provided on the CoQ-10 Supplements settlement website.
Class members who wish to object to or exclude themselves from the CoQ-10 Supplements settlement must do so by September 4, 2018. Class members who wish to participate in the settlement must submit a claim form on or before September 4, 2018.
Important Dates
- 9/4/18: Claim Form Deadline
- 9/4/18: Objection or Exclusion Deadline
- 11/29/18: Final Hearing at 9:00 am PT* (class members do not need to attend this hearing in order to receive a slice of the settlement pie).
*Settlement Class Members who wish to speak at the hearing should check www.Q10Settlement.com to confirm that the date or time of the Hearing has not been changed.
Contact Information
- Mail: Q10 Settlement, c/o Classaura Class Action Administration, 1718 Peachtree St. #1080, Atlanta, GA 30309
- Phone: 1-866-532-6710
- Email: Contact@q10settlement,com
Class Counsel
- Ronald A. Marron of Law Offices of Ronald A. Marron
Settlement Website